News
#Hyderabad Based Vaccine Manufacturer @BharatBiotech Announced That BBV152 , Its ... - Latest Tweet by IANS India
The latest Tweet by IANS India states, '#Hyderabad based vaccine manufacturer @BharatBiotech announced that BBV152 , its whole-virion inactivated #COVID19 vaccine candidate, has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III study.'
#Hyderabad based vaccine manufacturer @BharatBiotech announced that BBV152 (#Covaxin), its whole-virion inactivated #COVID19 vaccine candidate, has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III study. pic.twitter.com/STygsWxNHR— IANS Tweets (@ians_india) December 30, 2021
(The above story first appeared on LatestLY on Dec 30, 2021 09:00 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
